HC Wainwright & Co. Downgrades Loop Industries to Neutral

HC Wainwright & Co. analyst Amit Dayal downgrades Loop Industries (NASDAQ:LOOP) from Buy to Neutral.

HC Wainwright & Co. analyst Amit Dayal downgrades Loop Industries (NASDAQ:LOOP) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

European Medicines Agency Accepted Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer’s Disease

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril antibody[1], for the treatment of Early Alzheimer's disease (mild cognitive impairment due to Alzheimer's disease (AD)

BIIB